1[1]Pocock SJ, Henderson RA, Rickards AF, et al. Meta - analysis ofrandomised trials comparing coronaryangioplasty with bypasssurgery[J]. Lancet, 1995,346:1184-1189
2[2]Serruys PW, Unger F, Sousa E, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multives sel disease[ J ]. N Engl J Med, 2001,344:1117-1124
3[3]Serruys P, Jaegere P, Kiemeni JF, et al. For the BENESTENT Study Group. A comparison of balloon - expandable - stent im plantation with balloon angioplasty in patients with coronary heart disease[J]. N Engl J Med, 1994, 331:489-495
4[4]Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty:one year clinical fol low up of BENESENT trial[J]. J Am Coll Cardiol, 1996, 27: 255-261
同被引文献8
1Mehran R,Dangas G,Mintz GS,et al. In- stent restenosis:the great equalizer disappointing clinical outcomes with all interventional strategies[ J ]. J Am coll Cardiol, 1999,33 (suppl A): 66A
2Vrolix M C, Legrand V M, Reiber J H, et al. Heparincoated Wiktor stents im human coronary arteries (MENTOR trial). MENTOR Trial Investigators[J ]. Am J Cardiol, 2000,86: 385-389
3Suzuki T, Kopia G, Hayashis, et al. Stent - based delivery of sirolimus reduces neointimal formation in a porcine coronary model[ J ]. Circulation, 2001,104:1188-1193
4Raman VK, Edel man ER. Coated Stents: local pharmacology[J ]. Semin Interv Cardiol, 1998,3(3-4): 133-137
5Grube E,Getkens V,Rowold S,et al. Inhibition of instent restenosis by the Quanam drug eluting polymer stent: two year follow up[J]. J Am coll Cardiol, 2001,36(suppl A): 19
